Lip Cancer Risk Up for Some Solid Organ Transplant Recipients

This article originally appeared here.
Share this content:
Lip Cancer Risk Up for Some Solid Organ Transplant Recipients
Lip Cancer Risk Up for Some Solid Organ Transplant Recipients

TUESDAY, May 24, 2016 (HealthDay News) -- For solid organ transplant recipients, azathioprine dose and duration of immunosuppression are associated with increased risk of lip cancer, according to a study published in the June issue of the Journal of the American Academy of Dermatology.

Renhua Na, Ph.D., from the University of New South Wales in Sydney, and colleagues examined the correlation between the type, dose, and duration of iatrogenic immunosuppression and lip cancer. Data were included from a population-based cohort of all 4,141 adult liver, heart, and lung transplant recipients in Australia from 1984 to 2006. Longitudinal data were abstracted from medical records, and incident lip cancer (58 cases) and deaths (1,434 cases) were ascertained by linkage with national registries.

The researchers observed an increase in the risk of lip cancer with high mean daily dose of azathioprine (hazard ratio [HR], 2.28), longer immunosuppression duration (HR, 9.86), increasing year of age at transplantation (HR, 1.14), earlier era of transplantation (HR, 8.73), and smoking history (HR, 2.71).

"Higher doses of azathioprine increase lip cancer risk, with implications for managing immunosuppressed populations and our understanding of the relationship between solar ultraviolet radiation and lip cancer," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

GDM Found to Increase Risk for Postpartum Depression

GDM Found to Increase Risk for Postpartum Depression

Researchers find odds up even more if woman has suffered an earlier bout of depression

Cervical Cancer Mortality Higher Among Older, Black Women

Cervical Cancer Mortality Higher Among Older, Black Women

Rates rose when latest study excluded women who'd already undergone hysterectomy

Many Advanced NSCLC Patients Not Getting Helpful Treatment

Many Advanced NSCLC Patients Not Getting Helpful Treatment

Study found 21 percent went without therapy, even though it could boost survival

is free, fast, and customized just for you!

Already a member?

Sign In Now »